Skip to main content
OpenTrials
Completed

NCT Number: NCT05205213

Stepwise for the Treatment of Lateral Incisional Hernias

The best approach for lateral incisional hernia is not known. Posterior component separation (reverse TAR) offers the possibility of using the retromuscular space for medial extension of the challenging preperitoneal plane.

The main objective of the study was to describe the surgical techniques used and their outcomes in the open lateral approach for the treatment of L3-L4 European Hernia Society (EHS) classification Incisional hernias, comparing the results between reverse TAR and pure lateral retromuscular preperitoneal, and analyzing the short- and long- term complications, including patient-reported outcomes measures (PROMs).

The study report followed the recommendations for reporting outcomes in abdominal wall hernias, and the new international classification of abdominal wall planes (ICAP).

A multicenter retrospective observational study was conducted using a prospectively maintained database from three university hospitals in Spain specialized in complex abdominal wall reconstruction. All patients undergoing open abdominal wall repair through the previous lateral incision for L3-L4 IHs between February 2012 and January 2020 were identified. All patients were operated on by the senior surgeons responsible for the complex abdominal wall units of each participating center. Prior to conducting the study, the approval of the local ethics committee was obtained (ID:39/2019). Written informed consent was also obtained.

The diagnosis of IH was based on clinical examination and imaging from a computed tomography (CT). The investigator only included patients with L3-L4 IHs. Patients with primary lateral hernias, such as Spiegel, Grynfelt and Petit hernias were excluded. We also excluded all patients in which the lateral IH was a parastomal hernia.

Demographic data, patient comorbidities, different classifications of hernia complexity, Carolinas Equation for Determining Associated Risks (CeDAR) and intraoperative and postoperative data were collected All patients followed a similar preoperative optimization program, which included endocrinologic and nutritional evaluations, respiratory physiotherapy, and abstinence from smoking at least 1 month before surgery. Weight loss was extremely recommended but without any mandatory prerequisite.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Miguel Angel Garcia Ureña

Madrid, 28822, Spain

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with a lateral incisional hernia L3 European Hernia Society classification
  • Patients with a lateral incisional hernia L4 European Hernia Society classification
  • Patients older than 18 years old

Exclusion criteria

  • Midline incisional hernia.
  • Patients with a parastomal hernia
  • Patients with a primary midline ventral hernia
  • Patients with a primary lateral hernia.
  • Age under 18 years old

Treatment and study plan

Surgical Technique (lateral retromuscular preperitoneal)

Other

Open abdominal wall repair through the previous lateral incision for L3-L4 Incisional hernias

Other names: Surgical Technique (reverse TAR)

Primary outcomes

  1. Recurrence

    Time frame: At least 12 month

    Recurrence was defined as a bulge of the contents of the abdominal cavity or preperitoneal fat through an abdominal wall defect at the site of a previous abdominal wall hernia repair.

Secondary outcomes

  1. Surgical Site Occurrence

    Time frame: 30 days

    Surgical Site Occurrence: the definition standardized by the Ventral Hernia Working Group (VHWG) was used, which includes any SSI, and wound cellulitis, unhealed incisional wound, fascial disruption, skin or soft tissue ischemia, skin or soft tissue necrosis, serous or purulent drainage wound, suture abscess, seroma, hematoma, infected or exposed mesh, or development of an enterocutaneous fistula

  2. Surgical Site Occurrence Requiring Procedural Intervention (SSOPI)

    Time frame: 30 days

    Surgical Site Occurrence Requiring Procedural Intervention (SSOPI): any SSO requiring wound opening, wound debridement, suture removal, percutaneous drainage, or partial or complete removal of the mesh

  3. Surgical Site Infection (SSI)

    Time frame: 30 days

    Surgical Site Infection (SSI) was defined using the standardized CDC definition: "infection that occurs in the part of the body where surgery has been performed and includes superficial, deep, and organ / space types"

  4. Bulging

    Time frame: At least 12 month

    Bulging was defined as an area of weakness or asymmetry on inspection or exploration of the patient's abdominal wall, with no confirmed defects on CT.

  5. European Registry for Abdominal Wall Hernias Quality of Life scale ("EuraHS-QoL")

    Time frame: 24 months

    Quality of life study was developed using the "European Registry for Abdominal Wall Hernias Quality of Life" scale ("EuraHS-QoL"), a specific tool developed by the EHS, which compares the evolution of the patients between the preoperative and postoperative periods regarding pain, restriction and aesthetic appearance domains. The minimum value is 0 and maximum value is 10. Higher scores mean a worse outcome.

Sponsors and collaborators

Lead sponsor

Henares University Hospital

Other

Registry information

Important dates

Study start
2012
Primary completion
2020
Study completion
2021
First posted
Jan 25, 2022
Registry last updated
Feb 7, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.